It's a 44 page presentation so I'm not going to put it here but they have put expected revenue numbers out etc - using a 20% success probability it is worth at least $1.50. Using 100% I get about $5.00.
They are also only assuming 5% market share at this stage which is a very conservative assumption. Double the market share to 10% and double the shareprice targets.
Oh yeah - don't forget they are one of the few biotechs that fund it all themselves - they don't ask you for any cash - the only way to get shares is buying the on the ASX.
they have released sensational numbers on thrombow
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 45361991 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 6100521 | 8 |
View Market Depth
| Last trade - 09.59am 13/08/2025 (20 minute delay) ? |
| CT1 (ASX) Chart |
Day chart unavailable